Abstract
For evaluation of the effectiveness of a hydroactive polyurethane plaster in the treatment of keloid scars, an open study was conducted. 46 patients were included. An improvement of the clinical parameters could be detected in nearly all participants during the study time of 8–12 weeks. The handling of the plaster was easy, and the tolerability was mostly good. Therefore, this polyurethane dressing seems to be a further alternative in the still difficult therapy of keloid scars.
Introduction
Hypertrophic scars and keloids represent significant challenges in dermatology, resulting from dysregulated wound healing and excessive collagen production. While hypertrophic scars remain confined to the original wound site, keloids can grow beyond these boundaries, behaving like benign tumors that rarely regress spontaneously.
Conventional treatments often involve invasive procedures like surgical revision, cryosurgery, or laser therapy, which carry risks of "rebound" effects—triggering even more aggressive scarring. Conservative options like steroid injections or silicone sheets are available but can be painful or inconvenient for patients. This study, published in Aktuelle Dermatologie, evaluates a user-friendly, non-invasive alternative: a hydroactive polyurethane plaster (Hansaplast Scar Reduction).
Methods
The researchers conducted an open clinical study involving 46 patients (13 men, 33 women) aged 8 to 77 years. The primary intervention involved applying hydroactive polyurethane patches, cut to size, for at least 24 hours at a time over an 8-to-12-week period.
The study tracked five key clinical parameters:
- Redness (Rötung)
- Bulging/Thickness (Wulstigkeit)
- Roughness (Rauheit)
- Feelings of tension (Spannungsgefühl)
- Itching (Juckreiz)
Each parameter was assessed on a scale from "not present" to "strong." Notably, the study focused on polyurethane to investigate whether semi-occlusion—sealing the skin to increase hydration—is the primary therapeutic driver, rather than specific chemical interactions associated with silicone.
Key Results
The patient cohort consisted of 46 individuals with "keloid-like scars," primarily resulting from surgery (72%). Scars were located mostly on the chest, abdomen, and shoulders. Both "fresh" (3–12 months) and "old" (up to 2 years) scars were included.
The results were overwhelmingly positive across the 12-week period:
- Overall Success: 78.3% of patients showed significant improvement, with 21.7% achieving "normalization" (flat, irritation-free scars).
- Symptom Reduction: Redness, which was present in 100% of scars at the start, was absent in 73.9% of patients by the end. Significant flattening (reduction in bulging) was also observed, although the outline of the keloid often remained visible.
- Tolerability: 84.8% of patients rated the tolerability as "very good."
Key Insights and Discussion
A primary takeaway is the effectiveness of the "semi-occlusive" environment. By increasing tissue hydration and normalizing microcirculation, the polyurethane plaster helps regulate collagen remodeling. Interestingly, scar age was not a barrier; older scars responded as well as newer ones, indicating that the remodeling process in keloids remains active long after the initial injury.
Subjective relief, particularly regarding itching and tension, was a major factor in patient compliance. Rapid improvement in these bothersome symptoms led to high acceptance of the treatment. As shown in the clinical data, itching symptoms dropped from being present in 63% of patients to nearly 0% by the end of the study.
While the study suggests polyurethane is a highly effective alternative to silicone, it does have limitations. As an open study without a control group, observer bias is possible. Furthermore, the evaluation relied on subjective feedback and visual inspection rather than objective 3D imaging or ultrasound measurements.
Conclusion
Hydroactive polyurethane dressings offer a promising, non-invasive therapy for problematic scarring. They are easy to use and well-tolerated by patients. For stubborn keloids, the authors suggest these patches could be used in combination therapy—following steroid injections or laser treatment—to prevent recurrence and optimize cosmetic outcomes.
Summary updated